The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Berberine: a potential phytochemical with multispectrum therapeutic activities
Abstract
IMPORTANCE OF THE FIELD: The use of traditional medicines of natural origin is being encouraged for the treatment of chronic disorders, as synthetic drugs in such cases may cause unpredictable adverse effects. Berberine, a traditional plant alkaloid, is used in Ayurvedic and Chinese medicine for its antimicrobial and antiprotozoal properties. Interestingly, current clinical research on berberine has revealed its various pharmacological properties and multi-spectrum therapeutic applications. AREAS COVERED IN THIS REVIEW: An extensive search in three electronic databases (Unbound Medline, PubMed and ScienceDirect) and internet search engines (Scirus and Google Scholar) were used to identify the clinical studies on berberine, without any time constraints. This review elaborates the recent studies which reveal that with time, the drug has evolved with superior therapeutic activities. In addition, this review will also attract the attention of formulation scientists towards the issues and challenges associated in its drug delivery and the probable approaches that may be explored to help patients reap the maximum benefit of this potentially useful drug. WHAT THE READER WILL GAIN: A relatively large number of studies discussed here have revealed the possible areas where this phytochemical constituent can exhibit its therapeutic activities in the treatment of chronic ailments or diseases including diabetes, cancer, depression, hypertension and hypercholesterolemia. TAKE HOME MESSAGE: The potential of the drug remains to be harvested by designing a suitable formulation that could overcome its inherent low bioavailability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
General guidelines for methodologies on research and evaluation of traditional medicine
Solimene, U., Anderson, L. M., Briggs, D. G., Cardini, F., Chan, M., Chandra, S., Chang, I., Chaudhury, R. R., Cheraghali, A. M., Fong, H. H. S., et al. (2000) · Cited by 1,025
Chinese Herbal Medicine: Materia Medica
Bensky, D., Gamble, A., & Kaptchuk, T. J. (1986) · Medical Entomology and Zoology · Cited by 938
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 634
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592 · cited 1×
“Usually, P-gp does not play an important role in the vital body functions; but on the basis of interaction with foreign bodies at membrane level (P-gp--mediated efflux system), it may be considered that P-gp has a defensive role in the body, such as in the active transport of cytotoxic compounds and endotoxins from in…”
BackgroundRole of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 418
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Sun, Y., Xun, K., Wang, Y., & Chen, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330d95b · Cited by 417
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Self-citationMantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0448 · Cited by 353
Brusq, J.-M., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 343
Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.009 · Cited by 323
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Cardiovascular actions of berberine
Lau, C., Yao, X., Chen, Z., Ko, W., & Huang, Y. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00068.x · Cited by 281
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
Kong, W.-J., Zhang, H., Song, D.-Q., Xue, R., Zhao, W., Wei, J., Wang, Y.-M., Shan, N., Zhou, Z.-X., Yang, P., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2008.08.013 · Cited by 267
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Bansal, T., Jaggi, M., Khar, R., & Talegaonkar, S. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rc77 · Cited by 238
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
The involvement of P-glycoprotein in berberine absorption
Pan, G., Wang, G., Liu, X., Fawcett, J. P., & Xie, Y. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.t01-1-910403.x · Cited by 225
The P-glycoprotein multidrug transporter
Fardel, O., Lecureur, V., & Guillouzo, A. (1996) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00081-x · Cited by 223
On the mechanism of antidepressant-like action of berberine chloride
Kulkarni, S. K., & Dhir, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.043 · Cited by 222
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux
Loo, T. W., & Clarke, D. M. (2005) · Journal of Membrane Biology · doi:10.1007/s00232-005-0792-1 · Cited by 209
Zhou, J., Zhou, S., Tang, J., Zhang, K., Guang, L., Huang, Y., Xu, Y., Ying, Y., Zhang, L., & Li, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.056 · Cited by 208
Peng, W.-H., Lo, K.-L., Lee, Y.-H., Hung, T.-H., & Lin, Y.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.003 · Cited by 182
Antimicrobial activity of berberine—a constituent ofMahonia aquifolium
Čerňáková, M., & Košťálová, D. (2002) · Folia Microbiologica · doi:10.1007/bf02818693 · Cited by 174
Varma, M. V. S., Sateesh, K., & Panchagnula, R. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499196 · Cited by 161
Bansal, T., Akhtar, N., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.010 · Cited by 161
Sack, R. B., & Froehlich, J. L. (1982) · Infection and Immunity · doi:10.1128/iai.35.2.471-475.1982 · Cited by 158
Scientific Perspectives on Drug Transporters and Their Role in Drug Interactions
Zhang, L., Strong, J. M., Qiu, W., Lesko, L. J., & Huang, S. M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050095h · Cited by 153
Abidi, P., Zhou, Y., Jiang, J.-D., & Liu, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 152
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
Delié, F., & Blanco‐Prieto, M. J. (2005) · Molecules · doi:10.3390/10010065 · Cited by 150
Sachs‐Barrable, K., Thamboo, A., Lee, S. D., & Wasan, K. M. (2007) · PubMed · Cited by 142
Intestinal Drug Transporters: In Vivo Function and Clinical Importance
Kunta, J. R., & Sinko, P. J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489144 · Cited by 133
The berberis story: Berberis vulgaris in therapeutics.
Arayne, M. S., Sultana, N., & Bahadur, S. S. (2007) · PubMed · Cited by 127
Phytochemistry of Plants Used in Traditional Medicine
(1995) · doi:10.1093/oso/9780198577751.001.0001 · Cited by 123
Fatehi‐Hassanabad, Z., Jafarzadeh, M., Tarhini, A., & Fatehi, M. (2005) · Phytotherapy Research · doi:10.1002/ptr.1661 · Cited by 122
Cicero, A. F. G., Rovati, L. C., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296582 · Cited by 115
Kulkarni, S. K., & Dhir, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.002 · Cited by 113
Kaneda, Y., Torii, M., Tanaka, T., & Aikawa, M. (1991) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1991.11812586 · Cited by 109
Nassar, T., Rom, A., Nyska, A., & Benita, S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.021 · Cited by 107
Chiou, W. L., Chung, S. M., Wu, T. C., & Ma, C. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39093 · Cited by 106
Wu, W. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s8311 · Cited by 104
Lin, T., Kuo, H., Chou, F., & Lu, F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-58 · Cited by 95
Berberine-induced LDLR up-regulation involves JNK pathway
Lee, S., Lim, H., Park, J., Lee, K., Jang, Y., & Park, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.060 · Cited by 94
Sun, D., Abraham, S. N., & Beachey, E. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1274 · Cited by 91
Transporters and Drug Discovery: Why, When, and How
Kim, R. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050084o · Cited by 89
Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery
Varma, M. V. S., Perumal, O., & Panchagnula, R. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.015 · Cited by 89
Varma, M. V. S., & Panchagnula, R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20309 · Cited by 81
Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
Kang, D. G., Sohn, E. J., Kwon, E. K., Han, J. H., Oh, H., & Lee, H. S. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00005-3 · Cited by 74
Mechanism of vasodilatory effect of berberine in rat mesenteric artery
Chiou, W., Yen, M., & Chieh-Fu, C. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90832-b · Cited by 73
A biochemical study on the hypotensive effect of berberine in rats
Chun, Y. T., Yip, T. T., Lau, K. L., Kong, Y. C., & Sankawa, U. (1979) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(79)90085-5 · Cited by 59
Preparation and evaluation of a microemulsion for oral delivery of berberine
Gui, S., Gui, S. Y., Gui, S. Y., et al. (2008) · Die Pharmazie · doi:10.31083/ph.2008.8018 · Cited by 52
Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine
Swabb, E. A., Tai, Y. H., & Jordan, L. W. (1981) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1981.241.3.g248 · Cited by 41
Mechanism of the Aortic Relaxation Induced by Low Concentrations of Berberine
Wong, K. (1998) · Planta Medica · doi:10.1055/s-2006-957575 · Cited by 26
Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs.
Ölmez, E., & Ilhan, M. (1992) · PubMed · Cited by 24
[Effect of berberine on transit time of human small intestine].
Yuan, J., Shen, X. Z., & Zhu, X. (1994) · PubMed · Cited by 19
Bin, C., Lai-yuan, L., Fang, D.-C., et al. (1987) · Journal of Tongji Medical University · doi:10.1007/bf02888450 · Cited by 6
Hua, X. (2002) · Zhongguo yaolixue tongbao · Cited by 4
Research works printed but not linked: 21
- Patwardhan B, 1992, J Altern Complement Med, 3, 9
- Arayne MS, 2007, Pak J Pharm Sci, 20, 83
- Chevalier A. Encyclopedia of medicinal plants, Revised Edition. Sydney (AUS): Dorling Kindersley; 2001
- Sack RB, 2000, Altern Med Rev, 5, 175
- 10.1016/0014-4894(85)90047-5 · doi:10.1016/0014-4894(85)90047-5
- Kaneda Y, 1990, Tokai J Exp Clin Med, 15, 417
- Nair KP, 1970, Pediatr Clin India, 5, 45
- Choudhry VP, 1972, Indian Pediatr, 9, 143
- Sheng WD, 1997, East Afr Med J, 74, 283
- Swabb EA, 1981, Am J Physiol, 241, G248
- Yuan J, 1994, Zhongguo Zhong Xi Yi Jie He Za Zhi, 14, 718
- Szeto S, 2002, Turk J Med Sci, 32, 363
- Cicero AF, 2007, Arzneimittelforschung, 57, 26
- Olmez E, 1992, Arzneimittelforschung, 42, 1095
- 10.2165/00137696-200604040-00008 · doi:10.2165/00137696-200604040-00008
- 10.1016/j.ijpharm.2006.01.020 · doi:10.1016/j.ijpharm.2006.01.020
- Sachs-Barrable K, 2007, J Pharm Pharm Sci, 10, 319
- 10.1016/S0021-9673(02)00378-3 · doi:10.1016/s0021-9673(02)00378-3
- Lai J, 2010, Int J Nanomedicine, 5, 13
- Xin HW, 2002, Chin Pharmacol Bull, 18, 397
- Gui SY, 2008, Pharmazie, 63, 516
Cited by
Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., et al. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/627375 · Cited by 687
Neag, M. A., Mocan, A., Echeverría, J., Pop, R. M., Bocsan, C. I., Crişan, G., & Buzoianu, A. D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00557 · Cited by 562
Berberine: New perspectives for old remedies
Tillhon, M., Guamán Ortiz, L. M., Lombardi, P., & Scovassi, A. I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.018 · Cited by 477
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465
Berberis Vulgaris and Berberine: An Update Review
Imenshahidi, M., & Hosseinzadeh, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5693 · Cited by 359
Metadata
- Authors
- Vuddanda, P. R., Chakraborty, S., & Singh, S.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2010-09-13
- Volume
- 19
- Issue
- 10
- Pages
- 1297-1307
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2076903615
- Cited by
- 316
- References
- 64
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.